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background: The impact of ﬁbroids, not encroaching the endometrial cavity, have on the rate of success of IVF is still controversial.
Recent meta-analyses suggest a detrimental effect of intramural lesions but not subserosal lesions. However, they also emphasize the need
for further evidence. In order to elucidate this, we designed a prospective cohort study to compare the rate of success of IVF in women with
and without ﬁbroids.
methods: Exposed women were those with asymptomatic intramural or subserosal ﬁbroids with a diameter below 50 mm and who
were selected for IVF. Unexposed women were those free of ﬁbroids, who were matched to cases by age and number of previous IVF
cycles. All recruited patients underwent hystero-sonography to rule out intra-cavitary lesions.
results: There were 119 cases and 119 controls recruited. The number of clinical pregnancies in women with and without ﬁbroids was
28 (24%) and 22 (19%), respectively (P ¼ 0.43). The adjusted odds ratio (OR) for pregnancy in affected women was 1.38 [95% conﬁdence
interval (CI): 0.73–2.60]. The number of deliveries was 22 (18%) and 16 (13%), respectively (P ¼ 0.38). The adjusted OR was 1.45 (95% CI:
0.71–2.94). Similar results emerged when focusing exclusively on women carrying intramural lesions (n ¼ 80 couples). There was no signiﬁ-
cant relationship between clinical outcome and either the number or size of the ﬁbroids.
conclusions: In asymptomatic patients selected for IVF, small ﬁbroids not encroaching the endometrial cavity did not impact on the
rate of success of the procedure.
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Introduction
The relationship between uterine ﬁbroids and infertility has been a
critical and debated question for many years (Vercellini et al., 1998;
Somigliana et al., 2007; Klatsky et al., 2008). Even if there is a biological
plausibility supporting a causal relationship between ﬁbroids and infer-
tility, clinical data on this issue has been inconsistent and puzzling.
Observational evidence from case–control and cohort studies gener-
ally failed to document an association, but this may be due to confoun-
ders (Somigliana et al., 2007). In this context, IVF in women with
ﬁbroids has been estimated to be a model of utmost interest to
elucidate the relationship between these lesions and infertility.
At least, it allows assessment of the impact of ﬁbroids on the implan-
tation of the embryo. A plethora of studies and six meta-analyses
(Pritts, 2001; Donnez and Jadoul, 2002; Benecke et al., 2005; Somigli-
ana et al., 2007; Pritts et al., 2009; Sunkara et al., 2010) have been
published on this issue. There is an agreement that submucosal
ﬁbroids are detrimental, whereas subserosal lesions are not. The
impact of intramural ﬁbroids is more controversial. Whereas initial
meta-analyses failed to document an harmful impact (Pritts, 2001;
Donnez and Jadoul, 2002), the subsequent ones suggested a
reduced pregnancy rate among women carrying intramural lesions
(Benecke et al., 2005; Somigliana et al., 2007; Pritts et al., 2009;
Sunkara et al., 2010). The most recent meta-analysis included 19
studies and reported a relative risk of pregnancy and live birth in
women with ﬁbroids of 0.85 [95% conﬁdence interval (CI): 0.77–
0.94, P ¼ 0.002] and 0.79 (95% CI: 0.70–0.88, P, 0.0001), respect-
ively (Sunkara et al., 2010).
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Despite this growing body of evidence, the debate is still on-going.
Of relevance here is the scientiﬁc quality of the available evidence
(Pritts et al., 2009). Most studies are underpowered; only a minority
of studies are prospective; proper investigations of the uterine cavity
were not systematically performed and data have not been systemati-
cally controlled for age and number of cycles, which are two critical
variables inﬂuencing the success of IVF (Pritts, 2001; Somigliana
et al., 2007; Sunkara et al., 2010). Noticeably, meta-analyses cannot
overcome most of these limitations and, in general, they should not
be viewed as the referee of all controversial issues. The quality of
the studies underlying these analyses is crucial. For this reason, it is
deemed important to further explore this relevant aspect of reproduc-
tive medicine (Pritts et al., 2009). To this aim, we designed a prospec-
tive study recruiting women with ﬁbroids selected for IVF. Women
free of ﬁbroids who also required IVF represented the unexposed
group.
Materials and Methods
Patients who were selected for IVF between June 2007 and June 2009 at
the Infertility Unit of the Fondazione Ca` Granda Ospedale Maggiore Poli-
clinico were considered for study entry. Women were eligible as cases if
they were diagnosed with uterine intramural or subserosal ﬁbroids with
a mean diameter below 50 mm. This cut-off was decided based on pre-
vious comparative studies supporting a strong beneﬁt of surgery in the
advanced cases (Bulletti et al., 1999, 2004). The unexposed women
were matched to cases for age and number of cycles. Speciﬁcally, controls
corresponded to the subsequent woman with the same age (+1 year)
and the same number of previous failed treatment cycles. Both patients
who underwent classical IVF or IVF–ICSI were included. Exclusion criteria
for both groups were the report of menstrual abnormalities and previous
treatments for ﬁbroid (i.e. myomectomy, uterine artery embolization and
magnetic resonance imaging-focused ultrasound). Women previously
achieving a pregnancy through IVF were also excluded. Since the oocyte
donation program was not part of the treatments offered by our unit,
the study did not thus include any women undergoing this kind of treat-
ment. The local Institutional Review Board approved the study and all
recruited patients signed an informed consent.
All patients underwent transvaginal ultrasound between Day 1 and Day
8 of the cycle during the month preceding the beginning of hyperstimula-
tion. The precise location and dimension of the myomas were recorded at
this time. Both affected and unaffected women also underwent a hystero-
sonography to rule out intra-endometrial lesions. This assessment was
done by inserting an intrauterine device (sonde intrauterine standard,
C.D.D., Paris, France) and injecting 20–40 ml of sterile saline. Scanning
was done on two perpendicular planes (sagittal and coronary) during injec-
tion. Sonographic appearance of myomas was deﬁned as symmetrical, well
deﬁned, hypoechoic and heterogeneous masses (Parker, 2007). When the
ecographic appearance did not allow a reliable discernment between
ﬁbroid and adenomyosis, cases were excluded. Measurement of each
myoma was carried out in three planes (sagittal, coronal and axial) at
the level of maximum width. We included myomas with a minimum diam-
eter of 10 mm. A myoma with ≥50% of its diameter bulging out of the
uterine contour line was deﬁned as subserosal. Intramural ﬁbroids were
those mostly within the uterine shape (Vercellini et al., 1999; Bajekal
and Li, 2000). Myomas distorting the cavity line were deﬁned as submuco-
sal and patients with these lesions were not recruited. If more than one
myoma was identiﬁed, the mean diameter of the largest was used as a
reference. For location, women were considered to carry intramural
ﬁbroids if at least one of them was located intramurally, regardless of
the number of lesions. All ultrasound scans were performed by only
three physicians engaged for a long time in gynecological ecographies. Pre-
liminary experiments showed an inter- and intra-observer variability for
the measurement of the size of the myomas both consistently below 20%.
Patients were monitored and managed according to a standardized clini-
cal protocol as reported elsewhere (Somigliana et al., 2008). Brieﬂy, the
dose of gonadotrophins was determined on an individual basis according
to the characteristics of the patients as age, serum hormonal levels and
antral follicle count. Patients underwent serial transvaginal ultrasound
and hormonal monitoring during hyperstimulation. When three or more
leading follicles with a mean diameter .18 mm were visualized, 5000
IU of hCG was administered s.c. Oocyte retrieval was performed trans-
vaginally 36 h after the hCG injection. Embryo transfer was performed
48–72 h after the oocyte collection. Cycles were canceled if there was
a poor or hyper-response of ovaries. We deﬁned hyper-response as a
serum estradiol level .4000 pg/ml and/or more than 20 follicles ident-
iﬁed on ultrasound scan before hCG administration. Poor response was
deﬁned by the ecographic evidence of fewer than three follicles during
ovarian hyperstimulation. Clinical pregnancy was deﬁned as the ultrasono-
graphic demonstration of an intrauterine gestational sac 4 weeks after
embryo transfer. Implantation rate was calculated as the ratio between
the number of gestational sacks identiﬁed at this time and the number
of embryos transferred. An active follow-up on pregnancy outcome was
performed by checking data of the obstetrical department and by phone
contact.
Data analysis was performed using the Statistics Package for Social
Sciences (SPSS 15.0, Chicago, IL, USA). Data were compared using Stu-
dent’s t test, non-parametric unpaired Wilcoxon test, x2 test or Fisher’s
exact test, as appropriate. The main outcome chosen was clinical preg-
nancy rate. Baseline characteristics found to differ between the study
groups (P, 0.10) were entered into a logistic regression model to
control for confounders. The magnitude of the associations was quantiﬁed
using odds ratios (ORs). Probability values ,0.05 were considered statisti-
cally signiﬁcant. The sample size was calculated setting the type I and type
II errors at 0.05 and 0.20, respectively, and stating as clinically relevant
demonstrating a 2-fold greater chance of pregnancy among women
without ﬁbroids. The rate of success used to calculate the sample size
was the one observed in our unit in 2006, excluding women with ﬁbroids
(30%). On these bases, we estimated that the number of patients to be
enrolled was about 120 women per group.
Results
There were 240 women initially included in the study, 120 with
ﬁbroids and 120 unexposed patients. After inclusion, one case sub-
sequently declined to undergo treatment for personal reasons. The
corresponding control was also excluded, leaving 119 couples for
data analysis. A spontaneous pregnancy occurred in two women
with ﬁbroids before starting ovarian hyperstimulation. These patients
were included in the analysis. Baseline characteristics of the two
study groups are shown in Table I. The BMI was found to be signiﬁ-
cantly higher among women carrying ﬁbroids. The mean difference
was 1.5 kg/m2 (95% CI: 0.6–2.4 kg/m2). There was also a trend
toward a difference in the indications for the procedure (Table I).
Fibroids were isolated in 61 cases (51%). The numbers of women
carrying 2, 3, 4 and 5 lesions were 21 (18%), 21 (18%), 11 (9%)
and 5 (4%), respectively. In 80 cases (67%), there was at least one
intramural ﬁbroid. The mean+ SD and median (interquartile range)
diameter of the larger lesion per patient was 22+ 10 and 19
(15–27) mm, respectively.
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IVF outcomes in the two study groups are shown in Tables II and III.
The proportion of canceled cycles was signiﬁcantly higher in women
with ﬁbroids. In this group, we also detected a trend toward a
higher number of transferred embryos. The clinical pregnancy rate
and delivery rate per started cycle did not differ between the two
groups (Table III). The logistic regression model aimed at determining
the adjusted ORs of pregnancy included the BMI, the indication, the
item of canceled cycle and the number of embryos transferred. The
resulting adjusted ORs per started cycle for pregnancy and delivery
in affected women were 1.40 (95% CI: 0.72–2.75) and 1.53 (95%
CI: 0.73–3.23), respectively. Among women with ﬁbroids, we
observed six twin pregnancies and two triplets, whereas among unex-
posed patients there were two twins and no triplets. A trend to a
higher implantation rate was observed in women with ﬁbroids (P ¼
0.08) (Table III). The logistic regression model used to calculate the
adjusted OR for implantation in women carrying ﬁbroids included
the BMI and the indication. It resulted in an adjusted OR of 1.74
(95% CI: 0.98–3.08).
When including the two pregnancies occurring spontaneously, the
numbers of clinical pregnancies in women with and without ﬁbroids
were 28 (24%) and 22 (19%), respectively (P ¼ 0.43). The OR for
pregnancy in women carrying ﬁbroids adjusted for BMI and indication
for IVF was 1.38 (95% CI: 0.73–2.60). The numbers of deliveries were
22 (18%) and 16 (13%), respectively (P ¼ 0.38). The OR for delivery
in affected women adjusted for BMI and indication to IVF was 1.45
(95% CI: 0.71–2.94). The spontaneous abortion rates in women
with and without ﬁbroids were 21% (6 out of 28) and 27% (6 out
of 22), respectively (P ¼ 0.74). All deliveries lead to viable infants.
The impact of the ﬁbroids was also evaluated according to their
location, number and dimension. These results are brieﬂy summarized
in Table IV. No clear associations between clinical outcomes and these
factors emerged.
Discussion
In contrast to evidence from recent available meta-analyses, we failed
to observe a detrimental effect of ﬁbroids with a diameter ,50 mm
and not distorting the endometrial contour on the rate of success of
IVF. For the entire cohort, the adjusted ORs of pregnancy, implan-
tation and delivery in women with ﬁbroids were 1.38 (95% CI:
0.73–2.60), 1.74 (95% CI: 0.98–3.08) and 1.45 (95% CI: 0.71–
2.94), respectively. When speciﬁcally focusing on women carrying at
least one intramural lesion (n ¼ 80 couples), these ORs were 1.41
(95% CI: 0.67–2.98), 1.75 (95% CI: 0.90–3.39) and 1.36 (95% CI:
........................................................................................








Protocol of stimulationa 0.37
Long protocol 64 (55%) 58 (49%)
GnRH antagonist 53 (45%) 61 (51%)
Canceled cyclesa 0.006
Poor response 12 (10%) 7 (6%)
Hyper-response 8 (7%) 0 (0%)
Total dosage of rFSH
(IU)b
2719+ 1366 2696+ 1407 0.90
Duration of stimulation
(days)b
10.1+ 2.4 9.9+ 1.8 0.56
Serum estradiol at the
time of hCG injection
(pg/ml)b
1737+ 847 1849+ 950 0.44
Number of oocytes
retrievedb




1 13 (15%) 27 (27%)
2 31 (36%) 40 (39%)
3 42 (49%) 35 (34%)
Continuous variables were compared using the Student’s t test with the exception of
the serum estradiol levels that were compared using the Wilcoxon test.
Categorical variables were compared using the x2 test with the exception of the
canceled cycle item that was compared using the Fisher exact test.
aData refer to patients initiating the stimulation (117 cases and 119 controls). Two
cases had a spontaneous pregnancy before initiating the stimulation.
bData refer to patients undergoing oocyte retrieval (97 cases and 112 controls).
cData refer to patients undergoing embryo transfer (86 cases and 102 controls).
........................................................................................
Table I Baseline characteristics of women with and







Age (years)a 37.6+ 3.0 37.6+ 3.0 0.98
Previous IVF cyclesa 1.00
0 80 (67%) 80 (67%)
1 31 (26%) 31 (26%)
≥2 8 (7%) 8 (7%)
BMI (kg/m2) 22.9+ 3.9 21.3+ 3.1 0.001
Duration of infertility
(years)
3.2+ 2.4 2.9+ 1.8 0.25
Previous pregnancies 35 (29%) 28 (24%) 0.38
Previous gynecological
surgeryb
34 (29%) 27 (23%) 0.37
Day 3 serum FSH
(IU/ml)
7.5+ 3.2 7.9+ 3.2 0.38
Indication to IVF 0.39
Male factor 64 (54%) 51 (43%)
Tubo-peritoneal
factor




16 (13%) 18 (15%)
Mixed 19 (16%) 26 (22%)
Continuous variables were compared using the Student’s t test. Categorical variables
were compared using the x2 test.
aExposed and unexposed women were matched for age and number of treatment
cycles.
bMyomectomies were excluded as stated in the selection criteria.
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0.58–3.15), respectively. We also failed to document any signiﬁcant
relationship with the number and size of the lesions.
Some limits of the paper should be considered. First, one may
argue that the inclusion of women with subserosal lesions was
useless considering that the literature is more unanimous on the
benignity of these lesions. In this regard, it is however noteworthy
that there is a lack of consensus on the precise deﬁnition of
submucosal, intramural and subserosal locations (Somigliana et al.,
2007). This inevitably renders comparisons among studies difﬁcult.
In our study, we referred to the most commonly used classiﬁcation
of Bajekal and Li (2000). These authors support the following deﬁ-
nitions: submucous ﬁbroids are those that distort the uterine
cavity. Intramural ﬁbroids are those which do not distort the cavity
and with ,50% of the tumor protruding into the serosal surface
of the uterus. Fibroids protruding ≥50% out of the serosal surface
are considered subserosal. In fact, many subserosal ﬁbroids have
an intramural component. Moreover, this classiﬁcation does not
take into consideration the dimensions of ﬁbroids. Since the thick-
ness of a normal uterine wall is 15–20 mm, all ﬁbroids which do
not distort the uterine cavity and with a mean diameter of more
than 30–40 mm are classiﬁed as subserosal even if the lesion
takes up the entire uterine wall. Indeed, their diameter is inevitably
bulging out of the uterine contour line for more than 50%. Regard-
less of these anatomical considerations, it is noteworthy that our
results were extremely similar even when considering exclusively
women with intramural lesions. Our study power is, however, inevi-
tably lower for this speciﬁc location and, consequently, conclusions
are less deﬁnite. This is a main limitation of our investigation.
Despite the scientiﬁc debate regarding the classiﬁcation of ﬁbroids,
it has to be recognized that the concept of intramural lesions is
strongly eradicated in clinical practice. There is thus the need to
give clinicians clear and practical information for this location.
Further evidence is required. In our institution, we are currently dis-
cussing the possibility of extending our study, focusing exclusively on
intramural lesions. Given the necessity to provide evidence on the
delivery rate and not merely on the pregnancy rate, a further 18–
24 months will be needed from now to obtain deﬁnite data.
Secondly, some characteristics of the two groups slightly differed
and we cannot thus exclude some confounding factors. The BMI
was higher in women carrying ﬁbroids. This may be a confounder
since a higher BMI has been shown to negatively affect the rate
of success of IVF (Lunenfeld et al., 2004). We, however, estimate
that this difference did not play an important role since the magni-
tude is mild (1.5 kg/m2). Moreover, this confounder would be
expected to act to increase the detrimental role of ﬁbroids,
........................................................................................























Implantation ratec 17% 11% 0.08










The x2 test was used for comparisons.
PR, pregnancy rate; DR, delivery rate.
aData refer to patients initiating the stimulation (117 cases and 119 controls). Two
women with ﬁbroids had prior spontaneous pregnancies.
bData refer to patients performing oocyte retrieval (97 cases and 112 controls).
cData refer to patients performing embryo transfer (86 cases and 102 controls).
.............................................................................................................................................................................................
Table IV The impact of ﬁbroids on the clinical pregnancy rate according to location, number and size.
Subgroup No. of couples Clinical pregnancy Embryo implantation Delivery
Location
Intramural 80 1.41 (0.67–2.98) 1.75 (0.90–3.39) 1.36 (0.58–3.15)
Subserosal 39 1.22 (0.33–4.50) 1.22 (0.31–4.73) 1.60 (0.40–6.41)
Number
1 61 1.40 (0.56–3.46) 1.87 (0.84–4.16) 2.16 (0.73–6.41)
≥2 58 1.24 (0.50–3.09) 1.54 (0.67–3.53) 1.01 (0.38–2.68)
Size
,20 mm 60 1.31 (0.54–3.21) 2.09 (0.95–4.61) 1.55 (0.57–4.23)
≥20 mm 59 1.39 (0.55–3.50) 1.54 (0.64–3.66) 1.30 (0.47–3.61)
Data are reported as adjusted OR (95% CI) for pregnancy in women carrying ﬁbroids.
The implantation data refer to women performing embryo transfer, whereas the clinical pregnancy rate and the delivery rate refer to the whole cohorts.
The logistic regression model used to calculate the adjusted ORs included the BMI and the indication to the procedure.
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whereas, in contrast, we failed to show any effect. The ovarian
stimulation outcome also partially differed. Despite matching for
age, the proportion of canceled cycles and the number of trans-
ferred embryos were higher among women with ﬁbroids. These
two confounders are expected to inﬂuence the results in opposite
ways. Their impact is, however, presumably low. In fact, the preg-
nancy rate per transfer and the delivery rate per transfer which are
independent from the cancelation rate were similar in both groups.
In addition, the implantation rate, which is supposed to be indepen-
dent from both variables also, did not differ between groups. It
even tended to be higher in women with ﬁbroids (P ¼ 0.08). More-
over, in order to deﬁnitely rule out a relevant impact on the results
of the variables differing between the study groups, a logistic
regression model including BMI, indication for treatment, the item
of canceled cycle and the number of embryos transferred was
built. No signiﬁcant differences emerged from this analysis.
Finally, the grade of severity of the leiomyomatosis cases was
generally low. In half of the affected women, there was only one
lesion and the mean diameter of the ﬁbroids was relatively small
(22 mm). Our results cannot thus be inferred to the whole popu-
lation of women with ﬁbroids. Of relevance here is that a previous
report showed that only ﬁbroids larger than 40 mm would be detri-
mental (Oliveira et al., 2004). This is, however, a common
limitation of the vast majority of previous available studies on this
point (Somigliana et al., 2007; Pritts et al., 2009; Sunkara et al.,
2010).
On the other hand, our study has some important strengths. It is
prospective, the sample size is large, the uterine cavity was systemati-
cally investigated and unexposed women were matched for age and
number of cycles, thus controlling for two factors known to markedly
inﬂuence the rate of success of IVF. Matching also for ovarian respon-
siveness would have allowed us to better control also for this variable,
but our study design did not allow for this since, in order to properly
investigate the uterine cavity, the recruitment had to be done before
starting the stimulation.
How can we explain the incongruence between our data and recent
insights from meta-analyses? First of all, a type II error in our study
cannot be excluded. Despite a large sample size, the 95% CI of the
estimated OR remained relatively wide. Speciﬁcally considering intra-
mural lesions, the 95% CI of the associations with pregnancy and deliv-
ery of the meta-analysis (0.77–0.94 and 0.70–0.88) overlap with our
data (Sunkara et al., 2010). A much larger sample size would have
been required to deﬁnitely deny the results of these analyses.
However, a type II error may not be the unique reason. Other
factors may contribute to explain this contrasting result. Of relevance
here are the characteristics of the selected patients. It has ﬁrstly to be
pointed out that, in contrast to previous evidence, confounders are
less likely in our study since we used an age- and cycle-matching
design. Both variables are known to strongly affect the rate of
success of the procedure. Secondly, affected cases selected in all the
studies on this issue do not represent the entire population of infertile
women with ﬁbroids. In fact, a proportion of these women undergo
surgery prior to referral. The main reasons are non-infertile complaints
(menorrhagia or pelvic pain) and the severity of the disease. With
regard of the latter, it is noteworthy that uterine leiomyomata is a het-
erogeneous condition varying from a small single subserosal ﬁbroid to
multiple large lesions that radically distort pelvic anatomy.
Myomectomy has been shown to be effective in enhancing both
natural fertility and IVF success rates in severe cases (Bulletti et al.,
1999, 2004; Casini et al., 2006), but the question remains open for
less advanced conditions. Due to uncertainties on this point,
however, the policies leading women to surgery vary widely from
one center to the next and among clinicians. This inevitably translates
into differences in the characteristics of the ﬁbroids of the affected
women among studies.
In fact, the main problem now is delineating the limit between
unremarkable and harmful ﬁbroids. There is a need to go beyond
the arbitrary geometrical classiﬁcation and to reach a more
in-depth knowledge of this neglected but complex disease (Pritts
et al, 2009). Of further relevance here is the risk of
pregnancy-related complications of ﬁbroids. There is a need for a
more comprehensive vision of this topic. Obstetrical complications
arising after conception should also be considered. Although the
present study tends to rule out a remarkable impact on the risk
of abortion (the ORs of clinical pregnancy and delivery were
similar), other possible complications should be taken into consider-
ation. In particular, the most convincing evidence is in favor of an
association with pelvic pain, placental abruption, placenta previa,
intrauterine growth restriction and fetal malpresentation (Somigliana
et al., 2007). Not surprisingly, a higher rate of cesarean section has
also been repeatedly reported (Somigliana et al., 2007). On the
other hand, one has also to consider the risk of pregnancy after
a myomectomy. One of the major concerns here is the low,
albeit clinically relevant, risk of uterine rupture during pregnancy
or labor (Somigliana et al., 2007). Although these points have to
be kept in mind, their relative importance has yet to be clariﬁed
in the context of women selected for IVF. The above-mentioned
risks have been documented in women with more advanced clinical
conditions. Moreover, the recent improvement and diffusion of
laparoscopic excision techniques (all women selected in our study
are good candidates for this approach) may also modify the
scenario.
From a clinical point of view, we believe that, at present, there is
no indication to systematically remove ﬁbroids not encroaching the
endometrial cavity prior to initiating IVF. Our results did not indi-
cate any deleterious effect on the pregnancy rate. At least, this is
valid for asymptomatic patients with few small lesions as those
observed in our cohort. Some detrimental effects cannot,
however, be ruled out in some speciﬁc cases, but their identiﬁ-
cation is currently troublesome. Women should be informed
about this possible harmful effect on conception as well as about
pregnancy complications associated with ﬁbroids or their removal,
but they should also be reassured. In our view, surgery may be
considered for advanced cases, after repeated IVF failures or if
ﬁbroid-related obstetrical complications (i.e. recurrent miscarriage)
have been observed in the recent past.
In conclusion, our data suggests that, in asymptomatic patients
selected for IVF, small ﬁbroids with a diameter ,50 mm and not
encroaching the endometrial cavity do not impact on the rate of
success of the procedure. This result should not, however, be used
to conclude that all intramural or subserosal lesions are unremarkable.
In fact, current available evidence indicates that at least some lesions
may be deleterious. Future efforts should be aimed at identifying
this subgroup of women.
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